Internal Medicine, Pulmonary Disease · Vero Beach, FL
NPI
1568673630
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1000 36th St
Vero Beach, FL, 32960
Phone (772) 794-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
3,354 services
Medicare patients, 2024
1,007
Average age 77
Drug cost, 2024
$5.8M
4,563 prescriptions
Company payments, 2025
$32K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diego A Maldonado was code 99214 (office e&m - established), 929 times for 611 patients. In total Diego A Maldonado billed 3,354 services in 49 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 929 | 611 | $75.48 | $70K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 764 | 504 | $13.52 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 236 | 120 | $97.42 | $23K |
| 94010 Pulmonary Function Testing | Facility | 193 | 172 | $6.21 | $1,198 |
| 99291 Critical Care E&M | Facility | 177 | 111 | $177.42 | $31K |
| 99204 Office E&M - New | Facility | 130 | 130 | $100.47 | $13K |
| 99215 Office E&M - Established | Facility | 95 | 70 | $114.13 | $11K |
| 99223 Hospital E&M - Initial | Facility | 94 | 91 | $139.58 | $13K |
| 99215 Office E&M - Established | Office | 93 | 85 | $146.88 | $14K |
| 99406 Behavioral Health Services | Facility | 51 | 32 | $12.20 | $622 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 47 | 46 | $13.55 | $637 |
| 99292 Critical Care E&M | Facility | 47 | 24 | $89.85 | $4,223 |
| 94729 Pulmonary Function Testing | Facility | 42 | 42 | $7.18 | $302 |
| 94060 Pulmonary Function Testing | Facility | 42 | 42 | $8.25 | $347 |
| 94727 Pulmonary Function Testing | Facility | 42 | 42 | $9.59 | $403 |
By year: 2022 $242K for 3,475 services; 2023 $206K for 3,169 services; 2024 $220K for 3,354 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diego A Maldonado prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 615 prescriptions and refills. In total Diego A Maldonado wrote 4,563 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 615 | 1,159 | 176 | $728K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 498 | 759 | 188 | $20K |
| Prednisone Generic | 447 | 621 | 235 | $1,499 |
| Breo Ellipta Fluticasone/Vilanterol | 365 | 656 | 107 | $257K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 316 | 587 | 91 | $267K |
| Montelukast Sodium Generic | 221 | 614 | 83 | $2,690 |
| Ventolin Hfa Albuterol Sulfate | 160 | 219 | 73 | $13K |
| Azithromycin Generic | 151 | 331 | 57 | $2,288 |
| Doxycycline Hyclate Generic | 140 | 140 | 108 | $966 |
| Roflumilast Generic | 132 | 256 | 35 | $11K |
| Adempas Riociguat | 102 | 102 | 11 | $1.4M |
| Opsumit Macitentan | 102 | 102 | 11 | $1.3M |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 91 | 91 | 78 | $831 |
| Incruse Ellipta Umeclidinium Bromide | 77 | 169 | 24 | $58K |
| Symbicort Budesonide/Formoterol Fumarate | 65 | 118 | 24 | $27K |
Brand drugs: 2,669 claims; generic drugs: 1,894 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diego A Maldonado $32K ($32K in general payments such as food, travel and fees) from 14 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 22 | $24K |
| Intuitive Surgical, Inc. ISRG | 14 | $4,700 |
| Pulmonx Corporation LUNG | 6 | $836 |
| Johnson & Johnson Health Care Systems Inc. JNJ | 1 | $545 |
| Viatris Specialty LLC | 1 | $337 |
| GlaxoSmithKline, LLC. GSK | 11 | $233 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $200 |
| Verona Pharma, Inc. VRNA | 3 | $149 |
| Amgen Inc. AMGN | 2 | $147 |
| Boston Scientific Corporation BSX | 2 | $64.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.